Notoginsenoside Ft1 acts as a TGR5 agonist but FXR antagonist to alleviate high fat diet-induced obesity and insulin resistance in mice-Reference-Cited by-同舟云学术

Notoginsenoside Ft1 acts as a TGR5 agonist but FXR antagonist to alleviate high fat diet-induced obesity and insulin resistance in mice

Published:2021-06 Issue:6 Volume:11 Page:1541-1554
ISSN:2211-3835
Container-title:Acta Pharmaceutica Sinica B
language:en
Short-container-title:Acta Pharmaceutica Sinica B

Author:

Ding Lili,Yang Qiaoling,Zhang Eryun,Wang Yangmeng,Sun Siming,Yang Yingbo,Tian Tong,Ju Zhengcai,Jiang Linshan,Wang Xunjiang,Wang Zhengtao,Huang Wendong,Yang Li

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics

Reference55 articles.

1. The clinical biochemistry of obesity;Sikaris;Clin Biochem Rev,2004

2. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults;Calle;N Engl J Med,2003

3. Obesity: risk factors, complications, and strategies for sustainable long-term weight management;Fruh;J Am Assoc Nurse Pract,2017

4. Phenotypic alteration of hepatocytes in non-alcoholic fatty liver disease;Lakhani;Int J Med Sci,2018

5. Profile of obesity and comorbidities in elderly patients with heart failure;Dădârlat-Pop;Clin Interv Aging,2020

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Shengmai San formula alleviates high-fat diet-induced obesity in mice through gut microbiota-derived bile acid promotion of M2 macrophage polarization and thermogenesis;Phytomedicine;2024-10

2. Gut microbiota-brain bile acid axis orchestrates aging-related neuroinflammation and behavior impairment in mice;Pharmacological Research;2024-10

3. Effect of Ilex hainanensis Merr. On HFD-induced nonalcoholic fatty liver disease and rebalance of gut microbiota and bile acids metabolism in mice;Fitoterapia;2024-10

4. Bile Acids and Liver Cancer: Molecular Mechanism and Therapeutic Prospects;Pharmaceuticals;2024-08-30

5. Hepatic protein phosphatase 1 regulatory subunit 3G alleviates obesity and liver steatosis by regulating the gut microbiota and bile acid metabolism;Journal of Pharmaceutical Analysis;2024-08